Ren et al. humanize and structurally optimize a chimeric anti-SFTSV antibody, generating variants with markedly enhanced neutralization potency by strengthening binding to recombinant Gn and intact virions, providing full in vivo protection and establishing a generalizable framework for therapeutic antibody engineering.
Cancer is characterized by the uncontrolled cell proliferation, invasion, and check-point evasion of abnormal cells that are mostly nonfunctional. Cancer can arise due to diet insufficiencies, inherited mutations, and tobacco consumption, to say the least [1, 2]. Cancer’s incident is increasing due to the sedentary lifestyle, overpopulated, polluted megacities, and individuals’ growing desire for consuming processed foods containing preservatives additives [3], [4], [5]. Since cancers might not manifest symptoms in their early onset, it would be difficult or even improbable to treat them when they are diagnosed in their late stage. By and large, tumors are composed of two main parts, including the proliferating cells and stroma, which contains connective tissue and blood supply [6]. Chemotherapy has been among our best options against malignancies.
Chemotherapy is defined by the administration of numerous drugs and chemicals either alone or in combination to kill the cancer cells. Chemotherapeutic drugs kill cancer cells or control their progression all over the patient’s body, while radiation-and surgery-based treatments are directed to a particular site. Cure, control, and palliation are the three objectives of chemotherapies. Killing cancer cells by implementing chemotherapy drugs means “Cure”, whereas “Control” defines the situation that full remission seems far-fetched; therefore, the objective of the therapy would be to decrease the tumor size or to diminish the growth rate and angiogenesis. Palliation aims to alleviate the pain, symptoms, and medical conditions arisen due to cancer. It is mostly accomplished when cancer is in the advanced stages and cannot be eradicated; therefore, our aim would be to improve the quality of life.
The chemotherapy prescription approaches rely on various elements, including the cancer’s type, the cancer’s stage, the patient’s age, the patient’s general health status, the other concurrent health issues, and the history of receiving chemotherapies. Since chemotherapeutic drugs cannot distinguish normal cells against cancerous cells, the prescribed dosage is the other crucial aspect toward achieving the best possible response. The administration dosage depends on the patient’s weight, body surface area, age, nutrition status, history of radiation therapy, and blood cell count. Besides, a suitable drug administration schedule might help obtain the most efficient anti-cancer activity and minimum side effects [7, 8].
Chuanyu Guo & Akrit Sodhi explore how molecular stress (i.e., glucose dysregulation, dysmetabolism, oxidative stress, and inflammation) promotes retinal vascular cell and neuronal injury in patients with diabetes mellitus.
Address correspondence to: Akrit Sodhi, Wilmer Eye Institute, Johns Hopkins School of Medicine, 400 N. Broadway St., Smith Building, 4,039, Baltimore, Maryland 21,287, USA. Email: [email protected].
Find articles by Guo, C. in: | Google Scholar | 
Wilmer eye institute, johns hopkins university school of medicine, baltimore, maryland, USA.
In this Research Article, Marcus Altfeld & team identify a TLR8 gene mutation causing immune overactivation and inflammation in two siblings, linking genetic change to immune system dysfunction and disease: Immunology.
14 Hamburg Center for Translational Immunology;
15 German Center for Child and Adolescent Health (DZKJ), partner site Hamburg; and.
16 Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Researchers have identified a promising way to predict bloodstream infections in children with high-risk leukemia days before the infection would be diagnosed using current standards of care. The test, named plasma microbial cell-free DNA sequencing (mcfDNA-Seq), detected infection-causing pathogens days before standard blood cultures, offering a potential approach to protecting vulnerable patients by allowing treatment to start before the patient gets sick. The study is published in The Lancet Microbe.
Bloodstream infections are a major threat to children undergoing treatment for leukemia. Chemotherapy weakens the immune system, making even common bacteria or fungi potentially life-threatening. These infections can quickly lead to sepsis, prolonged hospital stays, delayed chemotherapy and, in some cases, early mortality. Catching these infections early is critical, yet clinicians currently have no reliable method to identify infections before symptoms appear.
“We’re not good at predicting or preventing infections in children with cancer, and the consequences can be deadly, causing lasting damage or delaying chemotherapy, which reduces the chances of successful treatment,” said first and corresponding author Joshua Wolf, Ph.D., MBBS, St. Jude Department of Infectious Diseases. “Many infections still happen even with the best prevention strategies we have, so what we really need is a way to detect infections before they start, so we can treat kids earlier and save lives.”
💬 Editor’s Note by JAMA Editorial Fellow Randi Bates and JAMA Deputy Editor Tracy Lieu: Adolescents face increasing rates of insufficient sleep, driven by early school start times and digital media use, undermining cognitive and mental health.
Insufficient sleep is one of the most common health risks in adolescents and is associated with worse cognitive performance and academic achievement, as well as depression, other mental health conditions, and physical concerns. The American Academy of Sleep Medicine and American Academy of Pediatrics (AAP) recommend adolescents aged 13 to 18 years sleep for 8 to 10 hours each night.1 Yet, studies have found that adequate sleep eludes most adolescents.2
In this issue of JAMA, Bommersbach and colleagues report worsening trends in insufficient sleep duration among US high school students based on an analysis of the national Youth Risk Behavior Survey.3 Insufficient sleep increased from 68.9% in 2007 to 76.8% in 2023, largely from increases in very short sleep durations of less than or equal to 5 hours per night. This trend was observed in all demographic groups and was generally consistent across subgroups characterized by behavioral risk factors.
These sweeping patterns suggest that structural and environmental factors may be driving increases in insufficient sleep at the population level. Although some studies have focused on changing individual behavior to increase sleep, such interventions may have limitations in adolescents whose self-regulatory and decision-making abilities are still maturing. Additionally, adolescents may lack sufficient agency to overcome school or social system barriers that limit sleep.
This surface protein complex for the Andes virus is a mushroom-shaped structure called a Gn-Gc tetramer. To map the 3D structures, the team first produced virus-like particles that mimic a real virus, but without the genome that makes a virus infectious. They then used a cryo-electron microscope—which shines an electron beam through a frozen sample and detects the shadows created by molecules—to reconstruct the three-dimensional structures of the Gn-Gc tetramers on the surface of the virus-like particles.
But there was a twist: To obtain extremely high-resolution structures, the researchers painstakingly identified and isolated shadows from only the tetramers that were pointing sidewise relative to the electron beam and ignored those pointing in other directions. This allowed them to borrow a reconstruction method typically used on individual proteins.
The resulting structures have an extremely high resolution of 2.3 angstroms, meaning details the size of just a couple of atoms were effectively captured. That’s enough to represent a transformational improvement over another team’s model of the tetramer from a few years ago, at a resolution of 12 angstroms, still tiny but large enough to produce some key inaccuracies – ones effectively corrected with the newer method and resulting structure.
These latest structures show the Gn-Gc tetramer in a particular state before it has infected a cell. For vaccines or antibody therapies to be most effective against a hantavirus, mimicking surface proteins at this pre-infection stage is essential. ScienceMission sciencenewshighlights.
Hantaviruses, transmitted from rodents to people, have a death rate approaching 40%. They’re found around the world, and because there are no approved vaccines or treatments, they’re among the pathogens of highest concern for future pandemics. They made news in the United States last year when Betsy Arakawa, the wife of actor Gene Hackman, died from a hantavirus infection in New Mexico in March.
New findings published in the journal Cell about the Andes virus, a hantavirus endemic to the southwestern U.S. and other parts of North and South America, represent a crucial first step towards much-needed vaccines and antibody therapies for this and other hantaviruses.
Researchers have identified a new type of blood-based biomarker test for Alzheimer’s disease that measures structural changes in proteins, providing more information on the underlying biology of the disease than standard blood tests. The findings, published in Nature Aging, also provide new insights into how Alzheimer’s disease biology may differ between males and females.
“This work introduces a fundamentally new, blood-based approach to detecting and staging Alzheimer’s disease,” said Dr. Richard Hodes, director of NIH’s National Institute on Aging (NIA). “By revealing protein structural changes associated with genetic risk, symptom severity, and sex differences—features not captured by existing biomarkers—this research could enable earlier diagnosis and more effective clinical trials.”
